Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions

American Journal of Roentgenology

Volumn 198, Issue 1, 2012, Pages 162-172

  Subhawong, Ty K ^a   Wang, Xin ^a   Durand, Daniel J ^a   Jacobs, Michael A ^a   Carrino, John A ^a   Machado, Antonio J ^a   Fayad, Laura M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Choline; MR spectroscopy; MRI; Musculoskeletal; Tumor

Indexed keywords

DIAGNOSTIC ACCURACY; GLYCOLYSIS; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LIMIT OF QUANTITATION; MULTIPLE MYELOMA; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL SYSTEM; NEUROECTODERM; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO;

ALGORITHMS; BONE NEOPLASMS; CHOLINE; CONTRAST MEDIA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; MUSCLE NEOPLASMS; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84455209470     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.6505     Document Type: Review

References (68)

1. Berquist TH, Ehman RL, King BF, Hodgman CG, Ilstrup DM. Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions. AJR 1990; 155:1251-1255
2. Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 1992; 185:581-586
3. Gielen JL, De Schepper AM, Vanhoenacker F, et al. Accuracy of MRI in characterization of soft tissue tumors and tumor-like lesions: a prospective study in 548 patients. Eur Radiol 2004; 14:2320-2330 (Pubitemid 40057945)
4. Fayad LM, Bluemke DA, McCarthy EF, Weber KL, Barker PB, Jacobs MA. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging 2006; 23:23-28 (Pubitemid 43100714)
5. Fayad LM, Barker PB, Jacobs MA, et al. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. AJR 2007; 188:1513-1520 (Pubitemid 46866852)
6. Hsieh TJ, Li CW, Chuang HY, Liu GC, Wang CK. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. J Comput Assist Tomogr 2008; 32:987-994
7. Fayad LM, Salibi N, Wang X, et al. Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. AJR 2010; 194:228; [web]W73-W79
8. Lee CW, Lee J, Kim DH, et al. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification. Clin Imaging 2010; 34:47-52
9. 1H MR spectroscopy in bone and soft tissue tumors. Chin Med J (Engl) 2009; 122:39-43
10. Fayad LM, Wang X, Salibi N, et al. A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T. AJR 2010; 195:207; [web]W69-W75
11. 1H MR spectroscopy: initial results. Radiology 2004; 232:599-605
12. Sah PL, Sharma R, Kandpal H, et al. In vivo proton spectroscopy of giant cell tumor of the bone. AJR 2008; 190:433; [web]W133-W139
13. Damron TA, Beauchamp CP, Rougraff BT, Ward WG Sr. Soft-tissue lumps and bumps. Instr Course Lect 2004; 53:625-637
14. Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am 1996; 78:656-663
15. De Graaf RA. In vivo NMR spectroscopy: principles and techniques, 2nd ed. West Sussex, England: Wiley, 2007
16. Bottomley PA, Lee Y, Weiss RG. Total creatine in muscle: imaging and quantification with proton MR spectroscopy. Radiology 1997; 204:403-410 (Pubitemid 27337486)
17. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989; 9:79-93 (Pubitemid 19044561)
18. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987; 508:333-348
19. Fayad LM, Barker PB, Bluemke DA. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy. Semin Musculoskelet Radiol 2007; 11:240-245 (Pubitemid 351272526)
20. Boesch C. Musculoskeletal spectroscopy. J Magn Reson Imaging 2007; 25:321-338
21. Wang CK, Hsieh TJ, Jaw TS, Lin JN, Liu GC, Li CW. Clinical application of in vivo proton (1 H) MR spectroscopy in musculoskeletal tumors. Spectroscopy 2005; 19:181-190
22. Lenkinski RE, Wang X, Elian M, Goldberg SN. Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast. Magn Reson Med 2009; 61:1286-1292
23. Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5 T and 3.0 T. Magn Reson Med 2001; 45:765-769 (Pubitemid 32402018)
24. Machann J, Stefan N, Schick F. (1)H MR spectroscopy of skeletal muscle, liver and bone marrow. Eur J Radiol 2008; 67:275-284
25. Boesch C, Machann J, Vermathen P, Schick F. Role of proton MR for the study of muscle lipid metabolism. NMR Biomed 2006; 19:968-988 (Pubitemid 44811551)
26. Natt O, Bezkorovaynyy V, Michaelis T, Frahm J. Use of phased array coils for a determination of absolute metabolite concentrations. Magn Reson Med 2005; 53:3-8 (Pubitemid 40110470)
27. 1H-MRS in vivo. Magn Reson Med 1999; 41:193-197
28. 1H magnetic resonance spectroscopy at 3.0 Tesla. Invest Radiol 2007; 42:327-337
29. in 't Zandt H, van Der Graaf M, Heerschap A. Common processing of in vivo MR spectra. NMR Biomed 2001; 14:224-232 (Pubitemid 32611434)
30. Mierisová S, Ala-Korpela M. MR spectroscopy quantitation: a review of frequency domain methods. NMR Biomed 2001; 14:247-259 (Pubitemid 32611436)
31. Vanhamme L, Sundin T, Hecke PV, Huffel SV. MR spectroscopy quantitation: a review of time-domain methods. NMR Biomed 2001; 14:233-246 (Pubitemid 32611435)
32. Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med 2001; 31:269-286 (Pubitemid 32378728)
33. Naressi A, Couturier C, Devos JM, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001; 12:141-152 (Pubitemid 32510133)
34. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30:672-679 (Pubitemid 23360802)
35. Sostman HD, Prescott DM, Dewhirst MW, et al. MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas. Radiology 1994; 190:269-275
36. Kreis R, Boesch C. Spatially localized, one- and two-dimensional NMR spectroscopy and in vivo application to human muscle. J Magn Reson B 1996; 113:103-118 (Pubitemid 126758755)
37. Zhu H, Barker PB. MR spectroscopy and spectroscopic imaging of the brain. Methods Mol Biol 2011; 711:203-226
38. Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA. Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 2004; 19:68-75 (Pubitemid 38055731)
39. Klijn S, De Visschere PJ, De Meerleer GO, Villeirs GM. Comparison of qualitative and quantitative approach to prostate MR spectroscopy in peripheral zone cancer detection. Eur J Radiol 2011 Jan 5 [Epub ahead of print]
40. 1H magnetic resonance spectroscopy in the liver: a review. Liver Int 2008; 28:297-307
41. Bredella MA, Ghomi RH, Thomas BJ, Miller KK, Torriani M. Comparison of 3.0 T proton magnetic resonance spectroscopy short and long echo-time measures of intramyocellular lipids in obese and normal-weight women. J Magn Reson Imaging 2010; 32:388-393
42. 1H MR spectroscopy. Radiology 2005; 236:609-614
43. Pfirrmann CWA, Schmid MR, Zanetti M, Jost B, Gerber C, Hodler J. Assessment of fat content in supraspinatus muscle with proton MR spectroscopy in asymptomatic volunteers and patients with supraspinatus tendon lesions. Radiology 2004; 232:709-715 (Pubitemid 39100252)
44. Mengiardi B, Schmid MR, Boos N, et al. Fat content of lumbar paraspinal muscles in patients with chronic low back pain and in asymptomatic volunteers: quantification with MR spectroscopy. Radiology 2006; 240:786-792 (Pubitemid 44267336)
45. Oya N, Aoki J, Shinozaki T, Watanabe H, Takagishi K, Endo K. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor. Radiat Med 2000; 18:193-198 (Pubitemid 30456710)
46. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999; 59:80-84 (Pubitemid 29062961)
47. Canese R, Iorio E, Ricci A, Pisanu ME, Giannini M, Podo F. Metabolite quantification in tumours by magnetic resonance spectroscopy: objectives, results and perspectives. Curr Med Imaging Rev 2009; 5:110-127
48. Jensen KE, Jensen M, Grundtvig P, Thomsen C, Karle H, Henriksen O. Localized in vivo proton spectroscopy of the bone marrow in patients with leukemia. Magn Reson Imaging 1990; 8:779-789
49. 1H magnetic resonance spectroscopy of bone marrow. MAGMA 2007; 20:93-101
50. 1H spectroscopy of human skeletal muscle: normal and pathologic findings. Magn Reson Imaging 1992; 10:957-964
51. Li CW, Kuo YC, Chen CY, et al. Quantification of choline compounds in human hepatic tumors by proton MR spectroscopy at 3 T. Magn Reson Med 2005; 53:770-776 (Pubitemid 40478423)
52. Herminghaus S, Pilatus U, Möller-Hartmann W, et al. Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors. NMR Biomed 2002; 15:385-392
53. Glunde K, Jie C, Bhujwalla ZM. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res 2004; 64:4270-4276 (Pubitemid 38802433)
54. Glunde K, Shah T, Winnard PT, et al. Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model. Cancer Res 2008; 68:172-180 (Pubitemid 351380118)
55. Li BS, Wang H, Gonen O. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging 2003; 21:923-928
56. Minati L, Aquino D, Bruzzone MG, Erbetta A. Quantitation of normal metabolite concentrations in six brain regions by in-vivo H-MR spectroscopy. J Med Phys 2010; 35:154-163
57. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006; 240:318-332
58. Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized proton NMR spectroscopy using stimulated echoes: applications to human skeletal muscle in vivo. Magn Reson Med 1991; 17:82-94
59. Rico-Sanz J, Hajnal JV, Thomas EL, Mierisová S, Ala-Korpela M, Bell JD. Intracellular and extracellular skeletal muscle triglyceride metabolism during alternating intensity exercise in humans. J Physiol 1998; 510:615-622 (Pubitemid 28370471)
60. Bárány M, Venkatasubramanian PN, Mok E, et al. Quantitative and qualitative fat analysis in human leg muscle of neuromuscular diseases by 1H MR spectroscopy in vivo. Magn Reson Med 1989; 10:210-226 (Pubitemid 19113181)
61. 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA 2006; 19:96-104
62. Soher BJ, Hurd RE, Sailasuta N, Barker PB. Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn Reson Med 1996; 36:335-339 (Pubitemid 26299257)
63. Fotedar LK, Slopis JM, Narayana PA, Fenstermacher MJ, Pivarnik J, Butler IJ. Proton magnetic resonance of exercise-induced water changes in gastrocnemius muscle. J Appl Physiol 1990; 69: 1695-1701
64. Forsberg AM, Nilsson E, Werneman J, Bergström J, Hultman E. Muscle composition in relation to age and sex. Clin Sci (Lond) 1991; 81:249-256
65. Eilber FC, Rosen G, Eckardt J, et al. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 2001; 19:3203-3209 (Pubitemid 32591437)
66. Davis AM, Bell RS, Goodwin PJ. Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 1994; 12:423-431 (Pubitemid 24056419)
67. De Schepper AM, De Beuckeleer L, Vandevenne J, Somville J. Magnetic resonance imaging of soft tissue tumors. Eur Radiol 2000; 10:213-223
68. Vanel D, Lacombe MJ, Couanet D, Kalifa C, Spielmann M, Genin J. Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy. Radiology 1987; 164:243-245 (Pubitemid 17089912)